cabazitaxel
Cabazitaxel was developed by Sanofi-Aventis and was approved by the U.S. FDA for the treatment of hormone-refractory prostate cancer on June 17, 2010. It is a semi-synthetic derivative of a natural taxoid. It is a microtubule inhibitor, and the fourth taxane to be approved as a cancer therapy.. Reference standards of Cabazitaxel API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below
stdClass Object
(
[pname] => Cabazitaxel N-formyl Impurity
[catalogue_number] => PA 03 01530
[category_ids] => ,78,80,79,71,75,
[chemical_name] =>
[weight] => 763.83
[form] => C41H49NO13
[cas] => NA
[pslug] => cabazitaxel-n-formyl-impurity-pa0301530
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Cabazitaxel N-formyl Impurity
Catalogue No.:PA 03 01530
Molecular Formula : C41H49NO13
Molecular Weight : 763.83
stdClass Object
(
[pname] => (2'S,3'R)-Cabazitaxel
[catalogue_number] => PA 03 01550
[category_ids] => 82,80,79,78,74,70,69
[chemical_name] =>
[weight] => 835.93
[form] => C45H57NO14
[cas] => 1714967-27-7
[pslug] => 1714967-27-7-2s-3r-cabazitaxel-pa0301550
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Catalogue No.:PA 03 01550
Molecular Formula : C45H57NO14
Molecular Weight : 835.93
stdClass Object
(
[pname] => (2'S, 3'R)-Cabazitaxel-D6
[catalogue_number] => PA STI 016880
[category_ids] => ,79,80,69,74,78,70,82,98,
[chemical_name] =>
[weight] => 841.97
[form] => C45H51D6NO14
[cas] => NA
[pslug] => 2s-3r-cabazitaxel-d6-pasti016880
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
(2'S, 3'R)-Cabazitaxel-D6
Catalogue No.:PA STI 016880
Molecular Formula : C45H51D6NO14
Molecular Weight : 841.97
stdClass Object
(
[pname] => 4-Deacetyl-4-propionyl Cabazitaxel-D6
[catalogue_number] => PA STI 024550
[category_ids] => ,79,80,69,74,78,70,82,98,
[chemical_name] =>
[weight] => 856.00
[form] => C46H53D6NO14
[cas] => NA
[pslug] => 4-deacetyl-4-propionyl-cabazitaxel-d6-pasti024550
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
4-Deacetyl-4-propionyl Cabazitaxel-D6
Catalogue No.:PA STI 024550
Molecular Formula : C46H53D6NO14
Molecular Weight : 856.00
stdClass Object
(
[pname] => Cabazitaxel - Impurity G
[catalogue_number] => PA 04 97670
[category_ids] => 69,70,74,78,79,80,82
[chemical_name] =>
[weight] => 1085.21
[form] => C58H72N2O18
[cas] => NA
[pslug] => cabazitaxel-impurity-g-pa0497670
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Catalogue No.:PA 04 97670
Molecular Formula : C58H72N2O18
Molecular Weight : 1085.21